These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 14681908)
1. Phenotypic characterization and genealogical tracing in an Afrikaner schizophrenia database. Karayiorgou M; Torrington M; Abecasis GR; Pretorius H; Robertson B; Kaliski S; Lay S; Sobin C; Möller N; Lundy SL; Blundell ML; Gogos JA; Roos JL Am J Med Genet B Neuropsychiatr Genet; 2004 Jan; 124B(1):20-8. PubMed ID: 14681908 [TBL] [Abstract][Full Text] [Related]
2. Genomewide scan in families with schizophrenia from the founder population of Afrikaners reveals evidence for linkage and uniparental disomy on chromosome 1. Abecasis GR; Burt RA; Hall D; Bochum S; Doheny KF; Lundy SL; Torrington M; Roos JL; Gogos JA; Karayiorgou M Am J Hum Genet; 2004 Mar; 74(3):403-17. PubMed ID: 14750073 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide scan in a large complex pedigree with predominantly male schizophrenics from the island of Kosrae: evidence for linkage to chromosome 2q. Wijsman EM; Rosenthal EA; Hall D; Blundell ML; Sobin C; Heath SC; Williams R; Brownstein MJ; Gogos JA; Karayiorgou M Mol Psychiatry; 2003 Jul; 8(7):695-705, 643. PubMed ID: 12874606 [TBL] [Abstract][Full Text] [Related]
4. Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. Tipping AJ; Pearson T; Morgan NV; Gibson RA; Kuyt LP; Havenga C; Gluckman E; Joenje H; de Ravel T; Jansen S; Mathew CG Proc Natl Acad Sci U S A; 2001 May; 98(10):5734-9. PubMed ID: 11344308 [TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of an Afrikaner founder population recruited for a schizophrenia genetic study. Roos JL; Pretorius HW; Karayiorgou M Ann N Y Acad Sci; 2009 Jan; 1151():85-101. PubMed ID: 19154519 [TBL] [Abstract][Full Text] [Related]
6. Origin and migration of an Afrikaner founder mutation FHAfrikaner-2 (V408M) causing familial hypercholesterolemia. Defesche JC; Van Diermen DE; Hayden MR; Kastelein JP Gene Geogr; 1996 Apr; 10(1):1-10. PubMed ID: 8913716 [TBL] [Abstract][Full Text] [Related]
7. Patterns of African and Asian admixture in the Afrikaner population of South Africa. Hollfelder N; Erasmus JC; Hammaren R; Vicente M; Jakobsson M; Greeff JM; Schlebusch CM BMC Biol; 2020 Feb; 18(1):16. PubMed ID: 32089133 [TBL] [Abstract][Full Text] [Related]
8. Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa. Le Saux O; Beck K; Sachsinger C; Treiber C; Göring HH; Curry K; Johnson EW; Bercovitch L; Marais AS; Terry SF; Viljoen DL; Boyd CD Hum Genet; 2002 Oct; 111(4-5):331-8. PubMed ID: 12384774 [TBL] [Abstract][Full Text] [Related]
9. Extended intermarker linkage disequilibrium in the Afrikaners. Hall D; Wijsman EM; Roos JL; Gogos JA; Karayiorgou M Genome Res; 2002 Jun; 12(6):956-61. PubMed ID: 12045148 [TBL] [Abstract][Full Text] [Related]
10. Deconstructing Jaco: genetic heritage of an Afrikaner. Greeff JM Ann Hum Genet; 2007 Sep; 71(Pt 5):674-88. PubMed ID: 17521310 [TBL] [Abstract][Full Text] [Related]
11. Identification of a common founder couple for 40 South African Afrikaner families with Parkinson's disease. Geldenhuys G; Glanzmann B; Lombard D; Boolay S; Carr J; Bardien S S Afr Med J; 2014 May; 104(6):413-9. PubMed ID: 25214250 [TBL] [Abstract][Full Text] [Related]
13. Identification and study of Utah pseudo-isolate populations-prospects for gene identification. Cannon-Albright LA; Farnham JM; Thomas A; Camp NJ Am J Med Genet A; 2005 Sep; 137A(3):269-75. PubMed ID: 16096997 [TBL] [Abstract][Full Text] [Related]
14. HLA haplotype map of river valley populations with hemochromatosis traced through five centuries in Central Sweden. Olsson KS; Ritter B; Hansson N; Chowdhury RR Eur J Haematol; 2008 Jul; 81(1):36-46. PubMed ID: 18363869 [TBL] [Abstract][Full Text] [Related]
15. Archival, demographic and genetic studies define a Sardinian sub-isolate as a suitable model for mapping complex traits. Angius A; Melis PM; Morelli L; Petretto E; Casu G; Maestrale GB; Fraumene C; Bebbere D; Forabosco P; Pirastu M Hum Genet; 2001 Aug; 109(2):198-209. PubMed ID: 11511926 [TBL] [Abstract][Full Text] [Related]
16. Genomic and genealogical investigation of the French Canadian founder population structure. Roy-Gagnon MH; Moreau C; Bherer C; St-Onge P; Sinnett D; Laprise C; Vézina H; Labuda D Hum Genet; 2011 May; 129(5):521-31. PubMed ID: 21234765 [TBL] [Abstract][Full Text] [Related]
17. Population isolates in South Tyrol and their value for genetic dissection of complex diseases. Marroni F; Pichler I; De Grandi A; Volpato CB; Vogl FD; Pinggera GK; Bailey-Wilson JE; Pramstaller PP Ann Hum Genet; 2006 Nov; 70(Pt 6):812-21. PubMed ID: 17044856 [TBL] [Abstract][Full Text] [Related]
18. Linkage disequilibrium mapping in the Newfoundland population: a re-evaluation of the refinement of the Bardet-Biedl syndrome 1 critical interval. Fan Y; Green JS; Ross AJ; Beales PL; Parfrey PS; Davidson WS Hum Genet; 2005 Jan; 116(1-2):62-71. PubMed ID: 15517396 [TBL] [Abstract][Full Text] [Related]
19. Strategies for phasing and imputation in a population isolate. Herzig AF; Nutile T; Babron MC; Ciullo M; Bellenguez C; Leutenegger AL Genet Epidemiol; 2018 Mar; 42(2):201-213. PubMed ID: 29319195 [TBL] [Abstract][Full Text] [Related]
20. Founder effect: assessment of variation in genetic contributions among founders. O'Brien E; Kerber RA; Jorde LB; Rogers AR Hum Biol; 1994 Apr; 66(2):185-204. PubMed ID: 8194843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]